Abstract
Although we tend to regard anxiety as a product of twentieth century living, anxiety, stress, and tension in their various forms must have been with man throughout his entire history. Indeed, as early as about 380 B.C., a statement was made by Plato in The Republic associating anxiety with a disease state: “Man is always fancying that he is being made ill, and is in constant anxiety about the state of his body” (Jowett, 1952). William Heberden also associated anxiety with disease in his celebrated lecture on angina pectoris to the Royal College of Physicians of London in 1768 (Heberden, 1772). During the last 50 years, thousands of papers have appeared in medical and scientific journals and dozens, if not hundreds, of books and monographs have been published on the pervasive subject of anxiety. “Indeed, anxiety has become the cornerstone of both psychosomatic medicine and psychiatric theory and practice” (Lief, 1967).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarskog, D.: Association between maternal intake of diazepm and oral clefts. Lancet 1975II/921
Abramowicz, M.: Benzodiazepine overdosage. Med. Lett. Drugs. Ther. 18, 60 (1976)
Aivazian, G.H.: Clinical evaluation of diazepam. Dis. Nerv. Syst. 25, 491–496 (1964)
Albanus, L., Jonsson, M., Sparf, B. Vessman, J.: A study of the induction effect of phenobarbital, diazepam und oxazepam in the dog. Acta Pharmacol. Toxicol. [Supp. 4] (Kbh), 55 (1971)
Allen, M.D., Greenblatt, D.J.: Hypnotics and sedatives. In: Side effects of drugs, Annual 2. Dukes, M.N.G. (ed.), pp. 36–44. Amsterdam: Excerpta Medica 1978
Almeyda, J.: Cutaneous reactions to imipramine and chlordiazepoxide. Br. J. Dermatol. 84, 298–300 (1971)
Almeyda, J. Levantine, A.: Drug reactions XVII. Cutaneous reactions to barbiturates, chloral hydrate and its derivatives. Br. J. Dermatol. 86, 313–316 (1972)
AMA Drug Evaluations: Sedatives and hypnotics, pp. 394–409. Antianxiety agents, 3rd ed., pp. 410–419. Littleton, Mass.: Publishing Sciences Group 1977
Anast, C.S.: Anticonvulsant drugs and calcium metabolism. N. Engl. J. Med. 292, 587–588 (1975)
Austin, T.R.: Mixed drug overdosage with phenelzine, amytal, and chlordiazepoxide. A case report. Anaesthesia 21, 249–252 (1966)
Ayd, F.J., Jr.: Oxazepam: An overview. Dis. Nerv. Syst. 36, Suppl., 14–16 (1975)
Bardhan, K.D.: Cerebellar syndrome after nitrazepam overdosage. Lancet 2, 1319–1320 (1969)
Barlow, S.M., Knight, A.F., Sullivan, F.M.: Delay in postnatal growth and development of offspring produced by maternal restraint stress during pregnancy in the rat. Teratology 18, 211–218 (1978)
Barlow, S.M., Knight, A.F., Sullivan, F.M.: Prevention by diazepam of adverse effects of maternal restraint stress on postnatal development and learning in the rat. Teratology 19, 105–110 (1979)
Barnett, A., Fiore, J.W.: Acute Tolerance to diazepam in cats and its possible relationship to diazepam metabolism. Eur. J. Pharmacol. 13, 239–243 (1971)
Barnett, A., Fiore, J.W.: Acute tolerance to diazepam in cats. In: The Benzodiazepines. Garattini, E.S., Mussini, E., Randall, L.O. (eds.), pp. 545–557. New York: Raven Press 1973
Barrett, J.E., DiMascio, A.: Comparative effects on anxiety of the “Minor Tranquilizers” in “High” and “Low” anxious student volunteers. Dis. Nerv. Syst. 27, 483–486 (1966)
Barry, J.E., Danks, D.M.: Anticonvulsants and congenital abnormalities. Lancet 1974II, 48–49
Baumes, R.M.: Cytopénies médicamenteuses: purpura, thrombopénique aigü et anticorps an-tiplaquettairs actifs en présence de Valium. Maroc. Med. 51, 321–324 (1971)
Beall, J.R.: Study of the teratogenic potential of diazepam and SCH 12041. Can. Med. Assoc. J. 106, 1061 (1972)
Beerman, H., Kirshbaum B.A.: Drug eruptions. In: Dermatology. Moschella, S.A., Phillsbury, D.M., Hurley, H.J. (eds.), pp. 350–384. Philadelphia: Saunders 1975
Bell, E.F.: The use of naloxone in the treatment of diazepam poisoning. J. Pediatr. 87, 803–804 (1975)
Bernards, W.: Case history number 74: Reversal of phenothiazine-induced coma with physostigmine. Anesth. Anal. (Cleve) 52, 938–941 (1973)
Bernstein, M.E., Hughes, F.W., Forney, R.B.: The influence of a new chlordiazepoxide analogue on human mental and motor performance. J. Clin. Pharmacol. 7, 330–335 (1967)
Berte, F., Manzo, L., De Bernardi, M., Benzi, G.: Ability of the placenta to metabolize oxazepam and aminopyrine before and after drug stimulation. Arch. Int. Pharmacodyn. Ther. 182, 182–185 (1969)
Betts, T.A., Clayton, A.B., MacKay, G.M.: Effects of four commonly used tranquilizers on low-speed driving performance tests. Br. Med. J. 4, 580–584 (1972)
Bibawi, E., Girgis, B., Abu-Khatwa, H.: Effect of hypnotics and psychotropic drugs on prothrombin level. J. Egypt. Med. Assoc. 46, 933–936 (1963)
Bieger, R., de Jonge, H., Loeliger, E.A.: Influence of nitrazepam on oral anticoagulation with phenprocoumon. Clin. Pharmacol. Ther. 13, 361–365 (1972)
Bitnun, S., Possible effect of chlordiazepoxide on the fetus. Can. Med. Assoc. J. 100,351 (1969)
Blackwell, B.: Psychotropic drugs in use today. J. Am. Med. Ass. 225, 1637–1641 (1973)
Bladin, P.F.: The use of clonazepam as an anticonvulsant — clinical evaluation. Med. J. Aust. 1, 683–688 (1973)
Blatchley, D.: Allergy to diazepam. Br. Med. J. 2, 287 (1977)
Blitt, C.D., Petty, W.C.: Reversal of lorazepam delirium by physostigmine. Anesth. Analg. (Cleve) 54, 607–608 (1975)
Bloomer, J.R., The hepatic prophyrias. Pathogenesis, manifestations, and management. Gastroenterology 71, 689–701 (1976)
Blum, J.E., Haefely, W., Jalfre, M., Polc, P., Scharer, K.: Pharmakologie und Toxikologie des Antiepileptikums Clonazepam. Arzneim. Forsch. 23, 377–389 (1973)
Bodendorfer, T.W.: Fetal effects of anticonvulsants drugs and seizure disorders. Drug. Intell. Clin. Pharm. 12, 14–21 (1978)
Boston Collaborative Drug Surveillance Program: Clinial depression in the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N. Engl. J. Med. 288, 277–280 (1973)
Brashares, Z.A., Conley, W.R.: Physostigmine in drug overdose. J. Am. Coll. Emerg. Physicians 4, 46–48 (1975)
Breckenridge, A.M., Orme, M.: Clinical implications of enzyme induction. Ann. N.Y. Acad. Sci. 179, 421–431 (1971)
Breckenridge, A.M., Roberts, J.B., Clinical significance of microsomal enzyme induction. Pharmacol. Res. Commun. 8, 229–242 (1976)
Brooks, S.M., Werk, E.E., Ackerman, S.J., Sullivan, I., Tracher, K.: Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma. N. Engl. J. Med. 286, 1125–1128 (1972)
Brophy, J.J.: Suicide attempts with psychotherapeutic drugs. Arch. Gen. Psychiatry 17, 652–657 (1967)
Browning, R.A., Maynert, E.W.: Phenobarbital, mephobarbital, and metharbital. In: Antiepileptic drugs. Woodbury, D.M., Penry, J.K., Schmidt, R.P. (eds.), pp. 345–351. New York: Raven Press 1972
Bruinsma, W.: A guide to drug eruptions. Amsterdam: Excerpta Medica 1973
Brunaud, M., cited by Tuchmann-Duplessis, H.: In: Influence des benzodiazepines sur la descendance. Rev. Med. 37, 2013–2023 (1976)
Brunaud, M., Rocand, J.: Une nouvelle benzodiazepine, le lorazepam. Mise au point pharma-cologique. Agressologie 213, 363–375 (1972)
Brunaud, M., Navarro, J., Salle, J., Siou, G.: Pharmalocogical, toxicological and teratological studies on dipotassium-7-chloro-3-carboxy-1,3-dihydro-2,2-dihydroxy-5-ühenyl-2H-1,4-benzodiazepine (dipotassium chloroazepate, 4306 Cb) a new tranquilizer. Arzneim. Forsch. 20, 123–125 (1970)
Burks, J.S., Walker, J.E., Rumack, B.H., Ott, J.E.: Tricyclic antidepressant poisoning. J. Am. Med. Ass. 230, 1405–1407 (1974)
Byck, R., Drugs and the treatment of psychiatric disorders. In: The pharmacological basis of therapeutics. Goodman, L.S., Gilman, A., (eds.), 5th ed., Chap. 12, pp. 152–200. New York. Macmillan 1975
Cannizarro, G., Nigito, S., Provenzano, P.M., Vitikova, T.: Modification of depressant and disinhibitory action of flurazepam during short term treatment in the rat. Psychopharma-cology 26, 173–184 (1972)
Carroll, B.J., Attempted suicide: Hyponotics and sedatives. Med. J. Aust. 2, 806 (1970)
Casier, H., Danechmand, L., De Schaepdryver, A., Hermans, W., Piette, Y.: Blood alcohol levels and psychotropic drugs. Arzneim. Forsch. 16, 1505–1506 (1966)
Cate, J.C., Jatlow, P.I.: Chlordiazepoxide overdose: interpretation of serum drug concentrations. Clin. Toxicol. 6, 553–561 (1973)
Chapallaz, S.: Intoxications aiguës par le nitrazépam (Mogadon). Schweiz. Apoth. Z. 111, 95–99 (1973)
Chapman, A.H.: Textbook of Clinical Psychiatry, 2nd ed., pp. 432–435. Philadelphia: Lippin-cott 1976
Chin, L.S., Havill, J.H., Rothwell, R.P.G., Bishop, B.G.: Use of physostigmine in tricyclic antidepressant poisoning. Anaesth. Intensive care 4, 138–140 (1976)
Chisolm, J.J.: The porphyrias. In: The principles and practice of medicine. Harvey, A.M., Johns, R.J., Owens, A.H., Ross, R.S. (eds.), 18th ed., pp. 630–640. New York: Appleton-Century-Crofts 1972
Cimo, P.L., Pisciotta, A.V., Desai, R.G., Pino, J.L., Aster, R.H.: Detection of drug-dependent antibodies by the 51Cr platelet lysis test: Documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole. Am. J. Hematol. 2, 65–72 (1977)
Clarke, T.P., Simpson, T.R., Wise, S.P., III: Two unsuccessful suicidal attempts with a new drug: methaminodiazepoxide (Librium). Tex. State. J. Med. 57, 24–26 (1961)
Cohen, M.M., Hirschorn, K., Frosch, W.A.: Cytogenetic effects of tranquilizing drugs in vivo and in vitro. J. Am. Med. Ass. 207, 2425–2426 (1969)
Cohen, S.N., Armstrong, M.A.: Drug interactions, p. 31. Baltimore: Williams & Wilkins 1974
Cohen, S.: Valium®: Its use and abuse. Drug. Abuse Alcohol News. 5, 1–4 (1976)
Cole, J.O.: Behavioral toxicology. In: Drugs and behavior. Uhr, L., Miller, J.G. (eds.), pp. 166–183. New York: Wiley & Sons 1960
Conney, A.H.: Drug metabolism and therapeutics. N. Engl. J. Med. 280, 653–660 (1969)
Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19, 317–366 (1967)
Cook, L., Davidson, A.B.: Effects of behaviorally active drugs in a conflict-punishment procedure in rats. In: The benzodiazepines. Garattini, E.S., Mussini, E., Randall, L.O. (eds.), pp. 327–345. New York: Raven Press 1973
Cooper, J.R. (ed.): Sedative-hypnotic drugs. Risks and benefits. U.S. Department of Health, Education, and Welfar. National Institute on Drug Abuse, Rockville, Md., 1977
Copperman, I.B.: Purpura in a patient taking chlordiazepoxide. Br. Med. J. 4, 485–486 (1967)
Crombie, D.C., Pinsent, R.J., Fleming, D.M., Rumeau-Rouquette, C., Goujard, J., Huel, G.: Fetal effects of tranquilizers in pregnancy. N. Engl. J. Med. 293, 198–199 (1975)
Cruz, I.A., Cramer, N.C., Parrish, A.E., Hemodialysis in chlordiazepoxide toxicity. J. Am. Med. Ass. 202, 438–440 (1967)
Cutler, S.J., Young, J.L. (eds.): Third national cancer survey: Incidence data. Natl. Cancer Inst. Monogr. 41, 102–103 (1975)
Czech, K., Francesconi, M., Haimbock, E., Hruby, K.: Die akute Vergiftung durch trizyklische Antidepressiva und ihre Therapie mit physostigminsalzylat. Wien, Klin. Wochenschr. 89, 265–269 (1977)
Danechmand, L., Casier, H., Hebbelinck, M., DeShaepdryver, A.: Combined effects of ethanol and psychotropic drugs on muscular tone in mice. Q.J. Stud. Alcohol. 28, 424–429 (1967)
Daunderer, M.: Physostigmin als Antidot bei einer Limbatril-Valium-Intoxikation. Dtsch. Med. Wochenschr. 103, 1245–1246 (1978)
Davis, J.M., Termini, B.A.: Attempted suicide with psychotropic drugs: Diagnosis and treatment (Part 1). Med. Counter Point 1, 43–49 (1969)
Degenhardt, K.H., Kerken, H., Knorr, K., Koller, S., Wiedemann, H.R.: Drug usage and fetal development: Preliminary evaluations of a prospective investigation. Adv. Exp. Med. Biol. 27, 467–479 (1972)
DeMatteis, F.: Disturbances of liver prophyrin metabolism caused by drugs. Pharmacol. Rev. 19, 523–557 (1967)
DeMatteis, F.: Toxic hepatic prophyrias. Semin. Hematol. 5, 409 (1968)
Devenyi, P., Wilson, M.: Barbiturate abuse and addiction and their relationship to alcohol and alcoholism. Can. Med. Assoc. J. 104, 215–218 (1971)
De Vries, S.I.: Haematological aspects during treatment with anticonvulsant drugs. Epilepsia 6, 1–15 (1965)
Di Liberti, J., O’Brien, M.L., Turner, T.: The use of physostigmine as an antidote in accidental diazepam intoxication J. Pediatr. 86, 106–107 (1975)
DiMascio, A., Barrett, J.E.: Comparative effects of oxazepam in “High” and “Low” anxious student volunteers. Psychosomatics 6, 298–302 (1965)
DiMascio, A., Meyer, R.E., Stifler, L.: Effects of imipramine on individuals varying in level of depression. Am. J. Psychiatry 125, 55–58 (1968)
Doss, M. (ed.): Prophyrins in human diseases. 1st Int. Porphyrin Meet., Freiburg IB, 1975. Basel: Karger 1976
Eales, L.: Acute porphyria: The precipitating and aggravating factors. S. Afr. J. Lab. Clin. Med. 17, 120–125 (1971)
Editorial: Barbiturates on the way out. Br. Med. J. 3, 725–726 (1975)
Edwards, V.E., Eadie, J.M.: Clonazepam — a clinical study of its effectiveness as an anticonvulsant. Proc. Austr. Assoc. Neurol. 10, 61–66 (1973)
Eerola, M., Baer, G.: Porphyrie und Anaesthesie. Fallbericht und Kurze Übersicht. Prakt. Anaesth. 11, 160–165 (1976)
Eisenberg, J.: Die hepatischen Porphyrien. Med. Klin. 68, 789–797 (1973)
Elder, G.H., Gray, C.H., Nicholson, D.C.: The prophyrias: A review. J. Clin. Pathol. 25, 1013–1033 (1972)
Ellison, R.J., Cancellaro, L.A.: A study in the management of anxiety with lorazepam. J. Clin. Pharmacol. 18, 210–219 (1978)
Fang, M.H., Ginsberg, A.L., Dobbins, W.O., III: Cholestatic jaundice associated with fluraze-pam hydrochloride. Ann. Intern. Med. 89, 363–364 (1978)
Farkas, G., Farkas, G.: L’effet teratogene des medicaments psychotropes. J. Pharmacol. (Paris) 5, Suppl. 2, 30 (1974)
Favazza, A.R.: Elevated erythrocyte sedimentation rates in chronic, mentally ill outpatients. Dis. Nerv. Syst. 34, 110–112 (1973)
Fedrick, J.: Epilepsy and pregnancy. A report from the Oxford record linkage study. Br. Med. J. 2, 442–448 (1973)
Fell, R.H., Dendy, P.R.: Severe Hypothermia and respiratory arrest in diazepam and glutethimide intoxication. Anaesthesia 23, 636–640 (1968)
Findley, J.D., Robinson, W.W., Peregrino, L.: Addiction to secobarbital and chloridazepoxide in the rhesus monkey by means of self-infusion preference procedure. Psychopharmacology 26, 93–114 (1972)
Finkle, B.S., McCloskey, K.L., Goodman, L.S.: Diazepam and drug associated deaths: A United States and Canadian Survey. J. Am. Med. Ass. 242, 429–434 (1979)
Forfar, J.O., Nelson, M.M.: Epidemiology of drugs taken by pregnant women: Drugs that may affect the fetus adversely. Clin. Pharmacol. Ther. 14, 632–642 (1973)
Foy, K.A., Abendschein, D.R., Lahcen, R.B.. Effects of benzodiazepines during gestation and infancy of Y-maze performance of mice. Pharmacol. Res. Commun. 9, 325–338 (1977)
Franks, E., Jacobs, W.H.: Cholestatic jaundice possible due to benzodiazepine-type drugs. Mo. Med. 72, 605–606 (1975)
Fraser, H.F., Isbel, H., Eisenman, A.J., Wikler, A., Pescor, F.T.. Chronic barbiturates intoxication; further studies. Arch. Intern. Med. 94, 34–41 (1954)
Freyhan, F.A.: Therapeutic implications of differential effects of new phenothiazine compounds. Am. J. Psychiatry 115, 577–585 (1959)
Ganguli, L.K., Sen, D., Chatterjee, P., Mandai, J.N.: Oxazepam overdosage. J. Indian Med. Assoc. 54, 424–425 (1970)
Gardos, G., DiMascio, A., Salzman, C., Shader, R.I.: Differential actions of chlordiazepoxide and oxazepam on hostility. Arch. Gen. Psychiatry 18, 757–760 (1968)
Gaul, L.E.: Fixed drug eruption from chlordiazepoxide. Arch. Dermatol. 83, 1010–1011 (1961)
Gault, F.P.: A review of recent literature on barbiturate addiction and withdrawal. Bol. Estud. Med. Biol. 29, 75–83 (1976)
Gebhart, G.F., Plaa, G.L., Mitchell, C.L.: The effects of ethanol alone and in combination with phenobarbital, chlorpromazine, or chlordiazepoxide. Toxicol. Appl. Pharmacol. 15, 405–414 (1969)
Gelehrter, T.D.: Enzyme induction (first of three parts). N. Engl. J. Med. 294, 522–526 (1976)
Gosh, J.S.: Allergy to diazepam and other benzodiazpines. Br. Med. J. 1, 902–903 (1977)
Gibson, J.E., Becker, B.A.: Effect of phenobarbital and SKF 525A on the teratogenicity of cyclophosphamide in mice. Teratology 1, 393–398 (1968)
Gilbert, J.E.: Ingestion of a massive dose of Librium. S.D. J. Med. 14, 307–309 (1961)
Gjerris, F.: Poisoning with chlordiazepoxide (Librium). Dan. Med. Bull. 13, 170–172 (1966)
Glass, E.: Personal communication 1979. Vital statistics of the United States, Mortality. US. Department of Health, Education, and Welfare
Gold, E. Gordis, L., Tonascia, J., Szklo, M.: Increased risk of brain tumors in children exposed to barbiturates. J. Natl. Cancer Inst. 61, 1031–1034 (1978)
Goldberg, H.L., DiMascio, A.: Psychotropic drugs in pregnancy. In: Psychopharmacology: A generation of progress. Lipton, M.A., DiMascio, A., Killam, K.F. (eds.), pp. 1047–1055. New York. Raven Press 1978
Goldberg, H.L., Finnerty, R.J.: A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety. Compr. Psychiatry 18, 147–155 (1977)
Goldberg, L.: Psychopharmacological effects of ethanol and CNS-active drugs. In: 3rd Int. Pharmacol. Congr, Sao Paulo, Abstrs, pp. 61–62, 1966
Goldberg, M.E., Manian, A.A., Efron, D.H.: A comparative study of certain pharmacologic responses following acute and chronic administrations of chlordiazepoixde. Life Sci. 6, 481–491 (1967)
Goldman, D.: The results of treatment of psychotic states with newer phenothiazine compounds effective in small doses. Am. J. Med. Sci. 235, 67–78 (1958)
Goodman, L., Gilman, A.: The pharmacological basis of therapeutics, p. 145. New York: Mac-millan 1941
Gove, P.B. (ed.): Websters’ Third New International Dictionary of the English Language — Unabridged. Springfield Ill. Merriam 1963
Greenberg, G., Inman, W.H.W., Weatherall, J.A.C., Adelstein, A.M., Haskey, J.C.: Maternal drug histories and congenital abnormalities. Br. Med. J. 2, 853–856 (1977)
Greenblatt, D.J.: Antianxiety agents. In: Drug effects in hospitalized patients. Miller, R.R., Greenblatt, D.J. (eds.), pp. 193–205. New York: Wiley & Sons 1976
Greenblatt, D.J., Shader, R.I.: The clinical choice of sedative-hypnotics. Ann. Intern. Med. 77, 91–100 (1972)
Greenblatt, D.J., Shader, R.I.: Benzodiazepines in clinical practice. New York: Raven Press 1974
Greenblatt, D.J., Shader, R.I.: Prazepam and lorazepam, two new benzodiazepines. N. Engl. J. Med. 299, 1342–1344 (1978 a)
Greenblatt, D.J., Shader, R.I.: Dependence, tolerance, and addiction to benzodiazepines: Clinical and pharmacokinetic considerations. Drug. Metab. Rev. 8, 13–28 (1978 b)
Greenblatt, D.J., Allen, M.D., Noel, B.J., Shader, R.I.: Acute overdose with benzodiazepine derivatives. Clin. Pharmacol. Ther. 21, 497–514 (1977)
Greenblatt, D.J., Woo, E., Allen, M.D., Orsulak, P.J., Shader, R.I.: Rapid recovery from massive diazepam overdose. J. Am. Med. Ass. 240, 1872–1874 (1978 a)
Greenblatt, D.J., Shader, R.I., Weinberger, D.R., Allen, M.D., MacLaughlin, D.S.: Effect of a cocktail on diazepam absorption. Psychopharmacology 57, 199–203 (1978 b)
Gundlach, R., Engelhardt, D.M., Hankoff, L., Paley, H., Rudorfer, L., Bird, E.: A double-blind outpatient study of diazepam (Valium and placebo). Psychopharmacology 9, 81–92 (1966)
Gupta, R.C., Kofold, J., Toxicological statistics for barbiturates, other sedatives, and tranquillizers in Ontario. A 10-year survey. Can. Med. Assoc. J. 94, 863–865 (1966)
Haerten, K., Poettgen, W.: Leukopenie nach Benzodiazepin-Derivaten. Med. Welt 26, 1712–1714 (1975)
Haider, I.: Evaluation of a new tranquilizer — Wy 4036 — in the treatment of anxiety. Br. J. Psychiatry 119, 597–598 (1971)
Hammer, W. Sjöqvist, F.: Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sci. 6, 1895–1903 (1967)
Harris, R.T., Claghorn, J.L., Schoolar, J.C.. Self administration of minor tranqzilizers as a function of conditioning. Psychopharmacology 13, 81–88 (1968)
Hartz, S.C., Heinonen, O.P., Shapiro, S., Siskind, V., Slone, D.: Antenatal exposure to mepro-bamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N. Engl. J. Med. 292, 726–728 (1975)
Harvey, S.C.: Hypnotics and sedatives. In: The pharmacological basis of therapeutics. 5th ed., Goodman, L.S., Gilman, A. (eds.), pp. 102–123. New York: Macmillan 1975
Hawkins, C.F., Meynell, J.J.: Macrocytosis and macrocytic anemia caused by anticonvulsant drugs. Q. J. Med. 27, 45–63 (1968)
Hayes, S.L., Pablo, G., Radomski, T., Palmer, R.: Ethanol and oral diazepam absorption. N. Engl. J. Med. 296, 186–189 (1977)
Heberden, W.: Some aspects of a disorder of the breast. Med. Trans. Royal Coll. Phys. Lond. 2, 59–67 (1772) Cited by Lie, J.T.: Recognizing coronary heart disease — selected historical vignettes from the period of William Harvey (1578–1657) to Adam Hammer (1818–1878). Mayo Clin. Proc. 53, 811–817 (1978)
Heinonen, O.P., Slone, D., Shapiro, S.: Birth defects and drugs in pregnancy, pp. 335–344. Littleton, Mass.: Publishing Sciences Group 1977
Heiser, J.F., Wilbert, D.E.: Reversal of delirium induced by tricyclic antidepressant drugs with physostigmine. Am. J. Psychiatry 131, 1275–1277 (1974)
Hillyer, D.M.: An overdose of “Valium”. Med. J. Aust. 1, 565 (1965)
Hoffer, A.: Lack of potentiation by chlordiazepoxide (Librium®) of depression or excitation due to alcohol. Can. Med. Assoc. J. 87, 920–921 (1962)
Holden, J.M.C., Itil, T.M.: Laboratory changes with chlordiazepoxide and thioridazine, alone and combined. Can. Psychiatr. Assoc. J. 14, 299–301 (1969)
Holinger, P.C., Klawans, H.L., Reversal of tricyclic-overdosage-induced central anticholinergic syndrome by physostigmine. Am. J. Psychiatry 133, 1018–1023 (1976)
Holliday, A.R.: The problem of a shifting definition of behavioral toxicity. In: Proc. Int. Congr. Coll. Int. Neuro-Psycho-Pharmacol. 1966. 5th ed., Brill, H., Cole, J.O., Diniker, P., Hippius, H., Bradley, P.B. (eds.), pp. 630–637. Amsterdam: Excerpta Medica Foundation 1967
Hollister, L.E.: Uses of psychotherapeutic drugs. Ann. Intern. Med. 79, 88–98 (1973)
Hollister, L.E.: Valium: A discussion of current issues. Psychosomatics 18, 44–58 (1977)
Hollister, L.E.: Clinical pharmacology of psychotherapeutic drugs, pp. 12–49. New York: Churchill Livingstone 1978
Hollister, L.E., Motzenbecker, F.P., Degan, R.O.: Withdrawal reactions from chlordiazepoxide (Librium). Psychopharmacology 2, 63–68 (1961)
Hollister, L.E., Bennett, J.L., Kimbell, I., Savage, C., Overall, J.E.: Diazepam in newly admitted schizophrenics. Dis. Nerv. Syst. 24, 746–750 (1963)
Hoogland, D.R., Miya, T.S., Bousouet, W.F.: Metabolism and tolerance studies with chlordi-azepoxide-2–14C in the rat. Toxicol. Appl. Pharmacol. 9, 116–123 (1966)
Horváth, T., Gógl, A., Ruzsa, C., Ludány, A., Jâvor, T.: Drug-induced manifestations of hereditary hepatopathy. Acta Med. Acad. Sci. Hung. 3, 219–228 (1974)
Hoskins, N.M.: Current drug therapy-barbiturates. Am. J. Hosp. Pharm. 33, 333–339 (1976)
Houghton, G.W., Richens, A.: The effect of benzodiazepines and pheneturide on phenytoin metabolism in man. Br. J. Clin. Pharmacol. 1, 344–345 (1974)
Hughes, F.W., Forney, R.B., Richards, A.B.: Comparative effects in human subjects of chlordiazepoxide, diazepam, and placebo on mental und physical performance. Clin. Pharmacol. Ther. 6, 139–145 (1965)
Hummler, H., Theiss, E.: Cited by Tuchmann-Duplessis, H.: In: Influence des benzodiazepines sur la descendance. Rev. Medecine 37, 2013–2023 (1976)
Ingram, I.M., Timbury, G.C.: Side-effects of Librium. Lancet 2, 766 (1960)
Isbel, H.: Abuse of barbiturates. J. Am. Med. Ass. 162, 660–661 (1956)
Isbell, H., Chrusciel, T.L.: Dependence liability of “non-narcotic” drugs. Bull. WHO 43, 49 (1970)
Istvan, E.J.: Drug-associated congenital abnormalities? Can. Med. Assoc. J. 103, 1394 (1970)
Jaffe, J.H.: Drug addiction and drug abuse. In: The pharmacological basis o therapeutics. 5th ed., Goodman, L.S., Gilman, A. (eds.), pp. 284–324. New York: Macmillan 1975
Jenner, F.A., Parkin, D.: A large overdose of chlordiazepoxide. Lancet 2, 322–323 (1961)
Johns, M.W.: Self-poisoning with barbiturates in England and Wales during 1959–1974. Br. Med. J. 1, 1128–1130 (1977)
Jowett, B. (tr.), Plato: The Republic, Book III, Section 407. In: The dialogues of Plato, Encyclopedia Britannia. Great Books of the Western World. Hutchins, R.M. (ed.), p. 337. New York: Random House 1952
Kaebling, R., Conrad, F.G.: Agranulocytosis due to chlordiazepoxide hydrochloride, J. Am. Med. Ass. 174, 1863–1865 (1960)
Kalter, H.. Teratogenicity, embryolethality, and mutagenicity of drugs of dependence. In: Chemical and biological aspects of drug dependence. Mule, S.J., Brill, H. (eds.), pp. 413–445. Cleveland: CRC Press 1972
Kanto, J., Iisalo, E.U.M., Hovi-Viander, M., Kangas, L.: A comparative study on the clinical effects of oxazepam and diazepam. Relationship between plasma level and effects. Int. J. Clin. Pharmacol. Biopharm. 17, 26–31 (1979)
Karch, F.E., Lasagna, L.: Adverse drug reactions — a critical review. J. Am. Med. Ass. 234, 1236–1241 (1975)
Kato, R., Chiesara, E.: Increase of pentobarbitone metabolism induced in rats pretreated with some centrally acting compounds. Br. J. Pharmacol. 18, 2938 (1962)
Kato, R., Vassanelli, P.: Induction of increased meprobamate metabolism in rats pretreated with some neurotropic drugs. Biochem. Pharmacol. 11, 779–794 (1962)
Kerry, R.J., Jenner, F.A.: A double blind crossover comparison of diazepam (Valium, RO 5–2,807) with chlordiazepoxide (Librium) in the treatment of neurotic anxiety. Psychophar-macology 3, 302–306 (1962)
Kinross-Wright, J., Cohen, I.M., Knight, J.A.: The management of neurotic and psychotic states with Ro 5–0690 (Librium). Dis. Nerv. Syst. 21, 23–26 (1960)
Kissin, B., Interactions of ethyl acohol and other drugs. In: The biology of alcoholism. Kissin, B., Bergleiter, H., (eds.), pp. 119–121, Vol. 3. New York: Plenum Press 1974
Klerman, G.L., DiMascio, A., Rinkel, M., Greenblatt, M.: The influence of specific personality patterns on the reactions of phrenotropic agents. In: Biological psychiatry. Masserman, J. (ed.), Vol. I, pp. 224–242. New York: Grune & Stratton 1959
Knudsen, K.B., Sparberg, M., Lecocq, F.: Porphyria precipitated by fasting. N. Engl. J. Med. 277, 350–351 (1967)
Koch-Weser, J., Greenblatt, D.J.: The archaic barbiturate hyponotics. N. Engl. J. Med. 291, 790–791 (1974)
Koch-Weser, J., Sellers, E.M.: Drug interactions with coumarin anticoagulants (second of two parts). N. Engl. J. Med. 285, 547–558 (1971)
Kolb, L.C., Modern clinical psychiatry, p. 952. Philadelphia: Saunders 1977
Kopmann, A.F.: Letter to editor. Anesth. Analg. (Cleve.) 51, 793–794 (1972)
Kuntzman, R., Jacobson, M., Conney, A.H.: Effect of phenylbutazone on Cortisol metabolism in man. Pharmacologist 8, 195 (1966)
Kuntzman, R., Jacobson, M., Levin, W., Conney, A.H.: Stimulatory effect of N-phenylbarbital (phetharbital) on Cortisol hydroxylation in man. Biochem. Pharmacol. 17, 565–571 (1968 a)
Kuntzman, R., Sernatinger, E., Tsai, I., Klutch, A.: New Methodology for studies of drug metabolism. In: Symposium “Importance of fundamental principles in drug evaluation”. Tedeschi, D., Tedeschi, R. (eds.), pp. 87–103. New York. Raven Press 1968 b
Kurland, A.A., Bethon, G.D., Michaus, M.H., Agallianos, D.D.: Chlorpromazine-chlordiaz-epoxide and chlorpromazine-imipramine treatment: Side effects and clinical laboratory findings. J. New Drugs 6, 80–95 (1966)
Kutt, H.: Interactions of antiepileptic drugs. Epilepsia 16, 393–402 (1975)
Lackner, H., Hunt, V.E.: The effect of Librium on hemostasis. Am. J. Med. Sci. 256, 368–372 (1968)
Lader, M.: Antianxiety drugs: Clinical pharmacology and therapeutic use. Drugs 12, 362–373 (1976)
Lader, M., Walters, A.J.: Hangover effects of hypnotics in man. Br. J. Pharmacol. 41, 412 (1971)
Lakos, P., Czeizel, E.: A teratological evaluation of anticonvulsant drugs. Acta Paediatr. Acad. Sci. Hung. 18, 145–153 (1977)
Larson, G.F., Huribert, B.J., Wingard, D.W.: Physostigmine reversal of diazepam-induced depression. Anesth. Analg. (Cleve) 56, 349–351 (1977)
Lasagna, L.: The role of benzodiazepines in nonpsychiatric medical practice. Am. J. Psychiatry 134, 656–658 (1977)
Lawton, M.P., Cahn, B.: The effects of diazepam (Valium®) and alcohol on psychomotor performance. J. Nerv. Ment. Dis. 136, 550–554 (1963)
Lief, H.I.: Anxiety Reactions. In: Comprehensive textbook of psychiatry. Freedman, A.M., Kaplan, H.I., (eds.), pp. 857–870. Baltimore: Williams and Wilkins Co. 1967
Linnoila, M., Hakkinen, S.: Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving. Clin. Pharmacol. Ther. 15, 368–373 (1974)
Linnoila, M., Mattila, M.J.: Drug interaction on psychomotor skills related to driving: Diazepam and alcohol. Eur. J. Clin. Pharmacol. 5, 186–194 (1973)
Linnoila, M., Otterström, S., Anttila, M.: Serum chlordiazepoxide, diazepam, and thioridazine concentrations after the simultaneous ingestion of alcohol or placebo drink. Ann. Clin. Res. 6, 4–6 (1974)
Lo, K.-J., Eastwood, I.R., Eidelman, S.: Cholestatic jaundice associated with chlordiazepoxide hydrochloride (Librium) therapy: Report of a case and review of the literaure. Am. J. Dig. Dis. 12, 845–949 (1967)
Loew, D.M., Taeschler, M.: Wirkungsspektren von Psychopharmaka: Ihre Ableitung und mögliche Bedeutung für die Therapie. Mod. Probl. Pharmacopsychiatry 1, 118–137 (1968)
Louis-Fernand, R.T.: Barbiturates and psychotherapy. In: Psychotherapeutic drugs. Usdin, E., Forrest, I.S. (eds.), pp. 1318–1333. New York: Dekker 1975
Lund, L.: Effects of phenytoin in patients with epilepsy in relation to its concentration in plasma. In: Biological effects of drugs in relation to their plasma concentrations. Davies, D.S., Prichard, B.N.C. (eds.), pp. 227–238. Baltimore: University Park Press 1973
Lundy, J.S., Osterberg, A.E.: Review of the literature on derivates of barbituric acid; chemistry; pharmacology; clinical use. Proc. Staff Meet., Mayo Clin. 4, Suppl., 386–416 (1929)
Luton, E.F., Finchum, R.N.: Photosensitivity reaction to chlordiazepoxide. Arch. Dermatol. 91, 362–363 (1965)
Lyubimov, B.I., Smolnikova, N.M., Strekalova, S.N.: Effect of diazepam on the development of the progeny. Biull. Eksp. Biol. Med. 78, 64–66 (1974)
Mackie, B.S., Mackie, L.E.: Antihistamines in the treatment of drug eruptions. Med. J. Aust. 2, 1034–1037 (1966)
MacLeod, S.M., Giles, H.G., Patzalek, G., Thiessen, J.J., Sellers, E.M.: Diazepam actions and plasma concentrations following ethanol ingestion. Eur. J. Clin. Pharmacol. 11, 345–349 (1977)
Magnus, I.A.: The cutaneous porphyrias. Semin. Hematol. 5, 380–408 (1968)
Magnus, R.V.: Once-a-day potassium clorazepate in anxiety. Br. J. Clin. Pract. 27, 449–452 (1973)
Malick, J.B., Sofia, R.D., Goldberg, M.E.: A comparative study of the effects of selected psychoactive agents upon three lesion-induced models of aggression in the rat. Arch. Int. Phar-macodyn. Ther. 181, 459–465 (1969)
Manoguerra, A.S. Ruiz, E.: Physostigmine treatment of anticholinergic poisoning. J. Am. Coll. Emerg. Physicians. 5, 125–127 (1976)
Margules, D.L., Stein, L.: Increase of “antianxiety” activity and tolerance of behavioral depression during chronic administration of oxazepam. Psychopharmacology 13, 74–80 (1968)
Marks, J.: The benzodiazepines: Use, overuse, misuse, abuse. Baltimore: University Park Press 1978
Marshall, W.J.: Enzyme induction by drugs. Ann. Clin. Biochem. 15, 55–64 (1978)
Matsuki, K., Iwamoto, T.: Development of tolerance to tranquillizers in the rat. Jpn. J. Pharmacol. 16, 191–197 (1966)
Matthew, H.: Acute barbiturate poisoning. Amsterdam: Excerpta Medica 1971
Matthew, H.: Barbiturates. Clin. Toxicol. 8, 495–513 (1975)
Matthew, H., Proudfoot, A.T., Aitken, R.L.B., Aitken, R.L.B., Raeburn, J.A., Wright, N.: Nitrazepam: A safe hypnotic. Br. Med. J. 3, 23–25 (1969)
McColl, J.D.: Teratology studies. Appl. Ther. 8, 48–52 (1966)
McColl, J.D., Robinson, S., Globus, M.: Effect of some therapeutic agents on the rabbit fetus. Toxicol. Appl. Pharmacol. 10, 244–252 (1967)
McDonald, R.L.: The effects of personality type on drug response. Arch. Gen. Psychiatry 17, 680–686 (1967)
Meilin, G.W.: Drugs in the first trimester of pregnancy and the fetal life of Homo sapiens. Am. J. Obstet. Gynecol. 90, 1169–1180 (1964)
Mennear, J.H.: Familial pharmacology. Am. Fam. Physician 15, 100–102 (1977)
Meyer, U.A., Schmid, R.: The Porphyrias. In: The metabolic basis of inherited disease, Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S., (eds.), pp. 1166–1220. New York: McGraw-Hill Book Co. 1978
Milkovich, L., van den Berg, J.B.: Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N. Engl. J. Med. 291, 1268–1271 (1974)
Miller, A.I., D’Agostino, A., Minsky, R.: Effects of combined chlordiazepoxide and alcohol in man. Q. J. Stud. Alcohol. 24, 9–13 (1963)
Miller, R.P., Becker, B.A.: The teratogenicity of diazepam metabolites in Swiss-Webster mice. Toxicol. Appl. Pharmacol. 25, 453 (1973)
Miller, R.P., Becker, B.A.: Teratogenicity of oral diazepam and diphenylhydantoin in mice. Toxicol. Appl. Pharmacol. 32, 53–61 (1975)
Milner, G.: The effect of antidepressants and “tranquilizers” on the response of mice to ethanol. Br. J. Pharmacol. 34, 370–376 (1968)
Milner, G.: Interaction between barbiturates, alcohol, and some psychotropic drugs. Med. J. Aust. 1, 1204–1207 (1970)
Milner, L.: Allergy to diazepam. Br. Med. J. 1, 144 (1977)
Misra, P.S., Letevre, A., Ishii, H., Rubin, E., Lieber, C.S.: Increase of ethanol, meprobamate, and pentobarbital metabolism after chronic ethanol administration in man and rats. Am. J. Med. 51, 346–351 (1971)
Morland, J., Setekleiv, J., Hattner, J.F.W., Stromsaether, C.E., Danielsen, A., Wethe, G.H.: Combined effects of diazepam and ethanol on mental and psychomotor functions. Acta Pharmacol. Toxicol. (Kbh.) 34, 5–15 (1974)
Nagy, J., Decsi, L.: Physostigmine, a highly potent antidote for acute experimental diazepam intoxication. Neuropharmacology 17, 469–475 (1978)
National Prescription Audit (U.S.A.), 1970–1976. I.M.S. International, Ambler, Pa Nelson, M.M., Fortar, J.O.: Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br. Med. J. 1, 523–527 (1971)
Newton, R.W.: Physostigmine salicyclate in the treatment of tricyclic antidepressant overdose. J. Am. Med. Ass. 231, 941–943 (1975)
New Zealand Committee on Adverse Drug Reactions: Reactions reported 1965–1968. NZ Med. J. 69, 96–99 (1969)
New Zealand Committee on Adverse Drug Reactions: Three-year survey of reactions, 1969–1971. NZ Med. J. 75, 100–104 (1972)
Norio, M., Isoaho, R., Idanpaan-Heikkila, J.: Interaction of benzodiazepines and ethanol on sleeping time in rats. Scand. J. Clin. Lab. Invest. 27, Supp. 116, 76 (1971)
Olivecrona, H.: Embryo-destroying effect of injected phenobarbital in the mouse. Acta Anat. (Basel) 58, 217–221 (1964)
O’Malley, K.: Safety of hypnotics. Br. Med. J. 1, 729 (1971)
O’Neil, J.T., Pogge, R.C.: Relative safety of self-inflicted overdose with relatively newer medications. Ariz. Med. 30, 484–485 (1973)
Orme, M., Breckenridge, A., Brooks, R.V.: Interactions of benzodiazepines with warfarin. Br. Med. J. 3, 611–614 (1972)
Owen, G., Smith, T.H.F., Agersborg, H.P.K.: Toxicity of some benzodiazepine compounds with CNS activity. Toxicol. Appl. Pharmacol. 16, 556–570 (1970)
Padfield, A., Watkins, J.: Allergy to diazepam. Br. Med. J. 1, 575–576 (1977)
Pare, C.M.B.: Umwanted effects of long-term medication in schizophrenia and depression. Pharmakopsychiatr. Neuropsychopharmakol. 9, 187–192 (1976)
Pearson, I.B.: Hypnotics and sedatives. In: Side effects of drugs. Dukes, M.N.G. (ed.), Annual I, pp. 21–29. Amsterdam: Excerpta Medica 1977
Pennington, G.W., Synge, V.M.: Chlordiazepoxide (“Librium”) overdosage. J. Ir. Med. Assoc. 49, 187–188 (1961)
Persaud, T.V.N.: Investigations on the teratogenic effect of barbiturates in experiments on animals. Acta Biol. Med. Ger. 14, 89–90 (1965)
Persaud, T.V.N., Herderson, W.M.: The teratogenicity of barbital sodium in mice. Arzneim. Forsch. 19, 1309–1310 (1969)
Pirola, R.D.: Drug metabolism and alcohol. P. 108. Baltimore: University Park Press 1978
Polacsek, E., Barnes, T., Turner, N., Hall, R., Weise, C.: Interactions of alcohol and other drugs. 2nd ed. Toronto: Addiction Research Foundation 1972
Plum, P.: Clinical and experimental investigations in agranulocytosis. London: Lervis & Co. 1937
Proudfoot, A.T., Park, J.: Changing patterns of drugs used for self-poisoning. Br. Med. J. 1, 90–93 (1978)
Rada, R.T., Kellner, R., Buchanan, J.G.: Chlordiazepoxide and alcohol: A fatal overdose. J. Forensic Sci. 20, 544–547 (1975)
Randall, L.O.: Pharmacology of methaminodiazepoxide. Dis. Nerv. Syst. 21, Suppl., 7–10 (1960)
Randall, L.O., Kappell, B.: Pharmacological activity of some benzodiazepines and their metabolites. In: The benzodiazepines. Garattini, E.S., Mussini, E., Randall, L.O. (eds.), pp. 27–51. New York: Raven Press 1973
Randall, L.O., Schallek, W., Heise, G.A., Keith, E.F., Bagdon, R.E.: The psychosedative properties of methaminodiazepoxide. J. Pharmacol. Exp. Ther. 120, 163–171 (1960)
Rapp, M.S.: Reaction to flurazepam. Can. Med. Assoc. J. 105, 1020–1021 (1971)
Redeker, A.G., Sterling, R.E.: The “glucose effect” in erythropoietic protoporphyria. Arch. Intern. Med. 121, 446–448 (1968)
Reggiani, G., Hürlimann, A., Theiss, E.: Some aspects of the experimental and clinical toxicology of chlordiazepoxide. Proc. Eur. Soc. Study Drug Toxic. 9, 79–97 (1968)
Richards, L.D.G.: Congenital malformations and environmental influences in pregnancy. Br. J. Prev. Soc. Med. 23, 218–225 (1969)
Richens, A.: Drug interactions in epilepsy. In: Drug interactions. Grahme-Smith, D.G. (ed.), pp. 239–249. Baltimore: University Park Press 1977
Richens, A., Houghton, G.W.: Effect of drug therapy on the metabolism of phenytoin. In: Clinical pharmacology of antiepileptic drugs. Schneider, H., Janz, D., Gardner-Thorpe, C, Meinardi, H., Scherwin, A.L. (eds.), pp. 87–96. Berlin-Heidelberg-New York: Springer 1975
Rickeis, K.: Drug treatment of anxiety. In: Psychopharmacology in the practice of medicine. Jarvik, M.E. (ed.), pp. 309–324. New York: Appleton-Century-Crofts 1977
Ringrose, C.A.D.: The hazard of neurotropic drugs in the fertile years. Can. Med. Assoc. J. 106, 1058 (1972)
Ristola, P., Pyoralo, K., Jalonen, K., Suhonen, O.: The effect of diazepam on the rate of warfarin metabolism in man, rabbit, and rat. Scand. J. Clin. Lab. Invest. 27, Suppl. 116, 18 (1971)
Robinson, D.S., Amido, E.L.: Interaction of benzodiazepines with warfarin in man. In: The benzodiazepines. Garattini, E.D., Mussini, E., Randall, L.O. (eds.), pp. 641–646. New York: Raven Press 1973
Robinson, D.S., Sylvester, D.: Interaction of commonly prescribed drugs with warfarin. Ann. Intern. Med. 72, 853–856 (1970)
Rogers, H.J., Haslam, R.A., Longstreth, J., Lietman, P.S.: Phenytoin intoxication during concurrent diazepam therapy. J. Neurol. Neurosurg. Psychiatry 40, 890–895 (1977)
Rosenberg, H.: Physostigmine reversal of sedative drugs. J. Am. Med. Ass. 229, 1168 (1974)
Rubin, E., Gang, H., Mirsa, P.S., Lieber, C.S.: Inhibition of drug metabolism by acute ethanol intoxication. Am. J. Med. 49, 801–806 (1970)
Safra, M.J., Oakley, G.P., Jr.: Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975II, 478–480
Salzman, C., DiMascio, A., Shader, I.R., Hazmatz, J.S.: Chlordiazepoxide, expectation and hostility. Psychopharmacology 14, 38–45 (1969)
Sarwer-Foner, G.J.: Recognition and management of drug-induced extrapyramidal reactions and “paradoxical” behavioural reactions in psychiatry. Can. Med. Assoc. J. 83, 312–318 (1960)
Savin, J.A.: Current causes of fixed drug eruptions. Br. J. Dermatol. 83, 546–549 (1970)
Saxen, I.: Associations between oral clefts and drugs taken during pregnancy. Int. J. Epidemiol. 4, 37–44 (1975)
Schaeffer, S.: Toxicity from drug overdosage in an eleven-year-old boy. Case report. Clin. Pediatr. (Phil.) 1, 103–104 (1962)
Schallek, W., Schlosser, W., Randall, L.O.: Recent developments in the pharmacology of the benzodiazepines. Adv. Pharmacol. Chemother. 10, 119–183 (1972)
Schardein, J.L.: Drugs as Teratogens. Pp. 149–150. Cleveland: CRC Press 1976
Schmid, R.: In: The metabolic basis of inherited disease. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S. (eds.), pp. 939–1012. New York: Blakiston Division, McGraw-Hill Book Co., 1966
Schmidt, W., Staiger, G.R.: Chromosome studies on bone marrow from Chinese hamsters treated with benzodiazepine tranquillizers and cyclophosphamide. Mutat. Res. 7, 99–108 (1969)
Scott, A.J., Ansford, A.J., Webster, B.H., Stringer, H.C.W.: Erythropoietic protoporphyria with features of a sideroblastic anaemic terminating in liver failure. Am. J. Med. 54, 251–259 (1973)
Seip, M.: Growth retardation, dysmorphic facies, and minor malformations following massive exposure to phenobarbitone in utero. Acta Paediatr. Scand. 65, 617–621 (1976)
Seixas, F.A.: Alcohol and its drug interactions. Ann. Intern. Med. 83, 86–92 (1975)
Sellers, E.M.: Addictive drugs: Disposition, tolerance and dependence. Drug Metab. Rev. 8, 5–11 (1978)
Setala, K., Nyyssonen, O.: Hypnotic sodium pentobarbital as a teratogen for mice. Naturwissenschaften 51, 413 (1964)
Shader, R.I., DiMascio, A.: Psychotropic drug side effects. Baltimore: Williams & Wilkins 1970
Shader, R.I., Greenblatt, D.J.: Clinical implications of benzodiazepine pharmacokinetics. Am. J. Psychiatry 134, 652–656 (1977)
Shader, R.I., Greenblatt, D.J., Salzman, C., Kochansky, G.E., Harmatz, J.S.: Benzodiazepines: Safety and toxicity. Dis. Nerv. Syst. 36, 23–26 (1975)
Shapiro, A.K.: Psychochemotherapy. In: Biological foundation of psychiatry. Grenell, R.G., Gabay, S. (eds.), Vol. 2, p. 819. New York: Raven Press 1976
Shepherd, M., Lader, M., Lader, S.: Hypnotics and sedatives. In: Side effects of drugs. Meyler, L., Herxheimer, A. (eds.), pp. 52–54. Amsterdam: Excerpta Medica 1972
Shideman, F.E.: Clinical pharmacology of hypnotics and sedatives. Clin. Pharmacol. Ther. 2, 313–344 (1961)
Shimkin, P.M., Shaivitz, S.A.: Oxazepam poisoning in a child. J. Am. Med. Ass. 196, 662–663 (1966)
Skupin, G., Franzke, H.G.: Tranxilium 20 (Dikalium-chlorazepat) als 24-Stunden-Tranquilizer. Med. Welt 26, 956–959 (1975)
Slater, S.D.: Megaloblastic anemia and chronic bromide intoxication. Br. J. Clin. Pract. 28, 97–100 (1974)
Slovis, T.L., Ott, J.E., Teitelbaum, D.T., Lipscomb, W.: Physostigmine therapy in acute tricyclic antidepressant poisoning. Clin. Toxicol. 4, 451–459 (1971)
Smith, M.E.: A comparative controlled study with chlordiazepoxide. Am. J. Psychiatry 117, 362–363 (1960)
Smith, M.E.: Suicidal attempt by oral ingestion of chlordiazepoxide (Librium). Clin. Med. 8, 72–74 (1961)
Snyder, B.D., Blonde, L., McWhirter, W.R.: Reversal of amitiyptyline intoxication by physostigmine. J. Am. Med. Ass. 230, 1433–1434 (1974)
Solomon, H.M., Abrams, W.B.: Interactions between digitoxin and other drugs in man. Am. Heart J. 82, 277–280 (1972)
Solomon, H.M., Barakat, M.J., Ashley, C.J.: Mechanisms of drug interaction. J. Am. Med. Ass. 216, 1997–1999 (1971)
Somers, G.F.: The evaluation of drugs for foetal toxicity and teratogenicity in the rat: A collaborative study by sixteen laboratories. Excerpta Medica Int. Congr. Ser. 115, 216–220 (1966)
Somers, G.F.: The evaluation of drugs for foetal toxicity and teratogenicity in the rabbit: A collaborative study by four laboratories. Excerpta Medica Int. Congr. Ser. 181, 227–234 (1968)
Spark, H., Goldman, A.S.: Diazepam intoxication in a child. Am. J. Dis. Child 109, 128–129 (1965)
Speidel, B.D., Meadow, S.R.: Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972II, 839–843
Stacher, G.: Intrahepatische cholestase nach einer hochdosierten kombinations therapie mit Diazepam und Barbituraten bei Tetanus-Patienten. Wien. Klin. Wochenschr. 85, 401–406 (1973)
Staiger, G.R.: Chlordiazepoxide and diazepam: Absence of effects on the chromosomes of diploid human fibroblast cells. Mutat. Res. 7, 109–115 (1969)
Staiger, G.R.: Studies on the chromosomes of human lymphocytes treated with diazepam in vitro. Mutat. Res. 10, 635–644 (1970)
Stein, L., Berger, B.D.: Psychopharmacology of 7-chloro-5-(0-chlorophenyl)-l, 3-dihydro-3-hydroxy-2H-l,4-benzodiazepin-2-one (lorazepam) in squirrel, monkey, and rat. Arzneim. Forsch. 21, 1072–1078 (1971)
Stenchever, M.A., Parks, K.J.: Some effects of diazepam on pregnancy in the Balb/c mouse. Am. J. Obstet. Gynecol. 121, 765–770 (1975)
Stenchever, M.A., Frankel, R.S., Jarvis, J.A., Veress, K.: Some effects of diazepam in human cells in vitro. Am. J. Obstet. Gynecol. 103, 836–842 (1969)
Stenchever, M.A., Frankel, R.S., Jarvis, J.A.: Effect of diazepam on chromosomes of human leukocytes in vivo. Am. J. Obstet. Gynecol. 107, 456–460 (1970a)
Stenchever, M.A., Frankel, R.S., Jarvis, J.A., Veress, K.: Effect of chlordiazepoxide hydrochloride on human chromosomes. Am. J. Obstet. Gynecol. 106, 920–923 (1970b)
Stevenson, I.H., Browning, M., Cooks, J., O’Mally, K.: Changes in human drug metabolism after long-term exposure to hypnotics. Br. Med. J. 4, 322–323 (1972)
Stolerman, I.P., Kumar, R., Steinberg, H.: Development of morphine dependence in rats: Lack of effect of previous ingestion of other drugs. Psychopharmacology 20, 321–336 (1971)
Straus, D.J., Vance, Z.B., Kasdon, E.J., Robinson, S.H.: Atypical lymphoma with prolonged systemic remission after splenectomy. Description of three cases. Am. J. Med. 56, 386–392 (1974)
Sullivan, F.M., McElhatton, P.R.: A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, Phenytoin, and primidone in mice. Toxicol. Appl. Pharmacol. 40, 365–378 (1977)
Svenson, S.E., Hamilton, R.G., A critique of overemphasis on side effects with the psychotropic drugs: An analysis of 18,000 chlordiazepoxide-treated cases. Curr. Ther. Res. Clin. Exp. 8, 455–464 (1966)
Szeberenyi, S., Szalay, K.S., Garattini, S.: Removal of plasma metyrapone in rats submitted to previous pharmacological treatment. J. Pharm. Pharmacol. 21, 201–202 (1969)
Taddeini, L., Watson, C.J.: The clinical porphyrias, sem. hematol. 5, 335–369 (1968)
Tanner, T.B., Moorhead, S.H.: High dose poisoning with diazepam (Valium) and survival in a two-year-old child. J. Med. Assoc. Ga. 57, 534–536 (1968)
Thomson, J., Glen, A.I.M.: A large overdosage of chlordiazepoxide. Lancet 1961 II, 722–723
Tobin, J.M., Lewis, N.D.C.: New psychotherapeutic agent, chlordiazepoxide. J. Am. Med. Ass. 174, 1242–1249 (1960)
Tobin, J.M., Bird, I.F., Boyle, D.E.: Preliminary evaluation of Librium (RO 5–0690) in the treatment of anxiety reactions. Dis. Nerv. Syst. 21, 11–19 (1960)
Tobin, J.M., Lorenz, A.A., Brousseau, E.R., Conner, W.R.: Clinical evaluation of oxazepam for the management of anxiety. Dis. Nerv. Syst. 25, 689–696 (1964)
Tschudy, D.P., Wellan, F.H., Collins, A., Hunter, G.: The effect of carbohydrate feeding on the induction of delta-aminolevulinic acid synthetase. Metabolism 13, 396–406 (1964)
Tschudy, D.: Acute intermittent porphyria. Semin. Hematol. 5, 370–379 (1968)
Tuchmann-Duplessis, H.: Influence des benzodiazepines sur la descendance. Rev. Medecine 37, 2013–2023 (1976)
Tuchmann-Duplessis, H.: Drug effects on the fetus. Sydney: Adis Press 1975
Tuchmann-Duplessis, H., Mercier-Parot, L.: Repercussions des neruoleptics et des antitumoraux sur le development prenatal. Bull. Acad. Suisse Sci. Med. 20, 490–526 (1964)
Vajda, F.J.E., Prineas, R.J., Lovell, R.R.H.: Interaction between phenytoin and the benzodiazepines. Br. Med. J. 1, 346 (1971)
Van Dam, F.E., Gribnau-Overkamp, M.J.H.: The effect of some sedatives (phenobarbital, glutethimide, chlordiazepoxide, choral hydrate) on the rate of disappearance of ethyl biscoumacetate from plasma. Folia Med. Neerl. 10, 141–145 (1967)
Van der Kleijn, E., Vree, T.B., Guelen, P.J.M.: 7-Chloro-1,4-benzodiazepines: diazepam, desmethyldiazepam, oxydiazepam, oxydesmethyldiazepam (oxazepam), and chlordiazepoxide. In: Psychotherapeutic drugs. Usdin, E., Forrest, LS. (eds.), Part II: Applications. Chap. V-I, pp. 997–1037. New York: Dekker 1977
Van der Kolk, B.A., Shader, R.L, Greenblatt, D.J.: Autonomic effects of psychotropic drugs. In: Psychopharmacology: A generation of progress. Lipton, M.A., DiMascio, A., Killam, K.F. (eds.), pp. 1009–1020. New York: Raven Press 1978
Varma, A.J., Fisher, B.K., Sarin, M.K.: Diazepam-induced coma with bullae and eccrine sweat gland necrosis. Arch. Intern. Med. 137, 1207–1210 (1977)
Vere, D.W.: Risks of everyday life-drugs. Proc. R. Soc. Med. 69, 105–107 (1976)
Vesell, E.S., Passananti, G.T., Viau, J.P., Epps, J.E., Di Carlo, F.J.: Effects of chronic praze-pam administration on drug metabolism in man and rat. Pharmacology 7, 197–206 (1972)
Victor, M., Adams, R.D.: Barbiturates. In: Harrison’s principles of internal medicine. Thorn, G.W., Adams, R.D., Braunwald, E., Isselbacher, K.J., Petersdorf, R.G. (eds.), pp. 721–725. New York: McGraw-Hill 1977
Walker, B.E., Patterson, A.: Induction of cleft palate in mice by tranquilizers and barbiturates. Teratology 10, 159–163 (1974)
Walters, A.J., Lader, M.H.: Hangover effects of hypnotics in man. Nature 229, 637–638 (1971)
Walzer, R.S., Kurland, M.L., Braun, M.: Clinical trial of methaminodiazepoxide (Librium). Am. J. Psychiatry 117, 456–457 (1960)
Welland, F.H., Hellman, E.S., Gaddis, E.M., Collins, A., Hunter, G.W., Jr., Tschudy, D.P.: Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria. 1. The effect of diet. Metabolism 13, 232–250 (1964)
Weston, J.K., Weston, K.: Adverse drug reactions. The scene revisited — An update. Clin. Toxicol. 10, 129–148 (1977)
White, B.J., Driscoll, E.J., Tjio, J., Smilack, Z.H.: Chromosomal aberration rates and intravenously given diazepam. J. Am. Med. Ass. 230, 414–417 (1974)
Whitfield, J.B., Moss, D.W., Neale, G., Orme, M., Breckenridge, A.: Changes in plasma glutamyl transpeptidase activity associated with alterations in drug metabolism in man. Br. Med. J. 1, 316–318 (1973)
Whitlock, F.A.: Suicide in Brisbane, 1956–1973: The drug-death epidemic. Med. J. Aust. 1, 737–743 (1975)
Wiberg, G.S., Colwell, B.B., Trenholm, H.L.: Toxicity of ethanol-barbiturate mixtures. J. Pharm. Pharmacol. 21, 232–236 (1969)
Wilcox, W.W.: A case of agranulocytosis. Alaska Med. 4, 31–32 (1962)
Wilson, J.G.: Embryotoxicity of drugs in man. In: Handbook of teratology. Wilson, J.G., Fraser, F.C. (eds.), Vol. I, pp. 309–355. New York: Plenum Press 1977
With, T.K.: Porphyrin metabolism and barbiturate poisoning: Observations on cases of acute and chronic poisoning. J. Clin. Pathol. 10, 165–167 (1957)
Yanagita, T., Takahashi, S.: Dependence liability of several sedativehypnotic agents evaluated in monkeys. J. Pharmacol. Exp. Ther. 185, 307–316 (1973)
Zall, H.: Chemotherapy of anxiety. In: Mind-influencing drugs. Goldberg, M., Eggelston, E. (eds.), pp. 153–223. Littleton: PSG 1978
Zbinden, G., Bagdon, R.E., Keith, E.F., Phillips, R.D., Randall, L.O.: Experimental and clinical toxicology of chlordiazepoxide (Librium®). Toxicol. Appl. Pharmacol. 3, 619–637 (1961)
Zileli, M.S., Telatar, F., Deniz, S., Iiter, E., Adalar, N.: Pseudohypersomolar nonketoacitotic coma due to oxazepam intoxication. Clin. Toxicol. 5, 337–341 (1972)
Zucker, H.S.: Strange behavior with oxazepam. N.Y. State J. Med. 72, 974 (1972)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hines, L.R. (1981). Toxicology and Side-Effects of Anxiolytics. In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67767-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-67767-0_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67769-4
Online ISBN: 978-3-642-67767-0
eBook Packages: Springer Book Archive